Topchoice Medical Co., Inc. (SHA:600763)

Topchoice Medical Co. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,895	2,859	2,832	2,697	2,758	2,083
Other Revenue	14.6	14.6	14.51	21.21	22.23	5.24
Revenue	2,910	2,874	2,847	2,719	2,781	2,088
Revenue Growth (YoY)	1.03%	0.96%	4.70%	-2.23%	33.18%	8.12%
Cost of Revenue	1,790	1,767	1,750	1,609	1,500	1,145
Gross Profit	1,120	1,107	1,097	1,110	1,281	942.99
Selling, General & Admin	349.72	348.23	338.22	312.81	283.39	247.64
Research & Development	59.65	58.95	55.65	54.03	59.13	40.06
Other Operating Expenses	4.56	4.93	6.79	6.11	7.55	4.49
Operating Expenses	416.71	415.28	402.41	374.62	351.35	292.66
Operating Income	702.9	691.34	694.35	734.97	929.37	650.34
Interest Expense	-43.95	-45.44	-55.01	-50.05	-28.91	-18.76
Interest & Investment Income	49.04	50.52	71.82	47.54	67.79	46.92
Currency Exchange Gain (Loss)	-	-	-	-	-	-0
Other Non Operating Income (Expenses)	-5.08	-5.3	-8.37	-6	-2.77	-5.26
EBT Excluding Unusual Items	702.91	691.13	702.78	726.46	965.49	673.23
Gain (Loss) on Sale of Investments	1.42	1.42	-	-	-	-
Gain (Loss) on Sale of Assets	0.13	0.14	-	-0.05	-0.02	-
Asset Writedown	-0.86	-0.86	-0.42	-0.51	-0.21	-0.34
Other Unusual Items	2.18	2.18	6.46	12.08	9.33	7.17
Pretax Income	705.77	694.01	708.82	737.98	974.58	680.07
Income Tax Expense	121.4	121.88	130.43	122.31	188.43	135.1
Earnings From Continuing Operations	584.37	572.13	578.39	615.68	786.15	544.96
Minority Interest in Earnings	-72.17	-70.7	-77.95	-67.41	-83.34	-52.34
Net Income	512.2	501.43	500.44	548.27	702.81	492.63
Net Income to Common	512.2	501.43	500.44	548.27	702.81	492.63
Net Income Growth	1.50%	0.20%	-8.72%	-21.99%	42.67%	5.69%
Shares Outstanding (Basic)	449	447	447	449	449	448
Shares Outstanding (Diluted)	449	447	447	449	449	448
Shares Change (YoY)	0.55%	0.15%	-0.50%	-0.09%	0.32%	-0.48%
EPS (Basic)	1.14	1.12	1.12	1.22	1.56	1.10
EPS (Diluted)	1.14	1.12	1.12	1.22	1.56	1.10
EPS Growth	0.90%	0%	-8.26%	-21.92%	42.21%	6.20%
Free Cash Flow	515.61	431.3	332.13	248.52	572.09	538.01
Free Cash Flow Per Share	1.15	0.96	0.74	0.55	1.27	1.20
Dividend Per Share	0.450	0.450	0.311	-	-	-
Dividend Growth	44.70%	44.70%	-	-	-	-
Gross Margin	38.48%	38.51%	38.53%	40.81%	46.06%	45.17%
Operating Margin	24.15%	24.06%	24.39%	27.03%	33.42%	31.15%
Profit Margin	17.60%	17.45%	17.58%	20.17%	25.27%	23.59%
Free Cash Flow Margin	17.72%	15.01%	11.67%	9.14%	20.57%	25.77%
EBITDA	791.39	779.18	779.55	816.57	1,001	712.99
EBITDA Margin	27.20%	27.11%	27.39%	30.04%	35.99%	34.15%
D&A For EBITDA	88.49	87.83	85.21	81.6	71.43	62.65
EBIT	702.9	691.34	694.35	734.97	929.37	650.34
EBIT Margin	24.15%	24.06%	24.39%	27.03%	33.42%	31.15%
Effective Tax Rate	17.20%	17.56%	18.40%	16.57%	19.34%	19.87%
Revenue as Reported	2,910	2,874	2,847	2,719	2,781	2,088
Advertising Expenses	-	22.93	21.54	23.41	20.87	14.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.